Healthcare -
Biotechnology - NASDAQ - US
$ 0.7352
-3.14 %
$ 40.5 M
Market Cap
-0.42
P/E
PRLD - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative PRLD - Prelude Therapeutics Incorporated
28.9 M
LAST VALUE
3.51%
2 YEAR CAGR
65.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR